Archives of Dermatology · 1991 · 123 citations · 19 references
MedicineDermatologyImmunologyHypersensitivityImmunopathologyInflammationCytotoxic T Lymphocyte ResponsesDrug-induced Skin ReactionsImmunopathology Of SkinInflammatory DermatosesInflammatory Skin DiseasesInflammatory Skin DisordersBullous DermatosesBullous Drug EruptionsCytokine-mediated Skin InflammationDrug-induced Bullous DermatosisImmunohistochemical MarkersImmunohistochemical StainingT-cell Mediated HypersensitivityT-cell Mediated Skin Disease
A patient with bromisovalum-induced toxic epidermal necrolysis showed pronounced delayed hypersensitivity to bromisovalum by patch testing. Biopsy specimens from the cutaneous lesion and the site of the positive patch test reaction were analyzed and compared immunohistologically. The findings were similar: most of the mononuclear cells disposed along the dermoepidermal junction and migrating into the epidermis were CD8-positive lymphocytes, whereas the dermal inflammatory infiltrates were composed predominantly of CD4-positive lymphocytes. This case showed the potential usefulness of patch testing in evaluating cases of toxic epidermal necrolysis. We believe that delayed hypersensitivity plays a crucial role in the development of drug-induced toxic epidermal necrolysis. Furthermore, potential effector cells with phenotypic characteristics of CD8-positive lymphocytes (suppressor/cytotoxic T cells) seem to represent important mediators of the epidermal damage of the cutaneous lesion in our case.
19
Toxic Epidermal Necrolysis in a Patient With Graft-vs-Host Reaction
Gary L. Peck · Archives of Dermatology · 1972 · 121 citations
Medicine, Dermatology, Pathology +16
Cutaneous Manifestations of Graft‐Versus‐Host Disease
J.‐H. Saurat · International Journal of Dermatology · 1981 · 121 citations
Medicine, Dermatology, Immunology +14